ByTrending Posts
How Novo Nordisk and Deep Apple’s $812M AI-Powered…
Key Highlights: A Bold Break from Incretin DependencyNovo Nordisk’s new alliance with Deep Apple Therapeutics marks a critical…
How Will HEALWELL AI and Orion Health Transform…
Key Highlights: Strategic Expansion into US Healthcare MarketHEALWELL AI Inc., following its acquisition of Orion Health, announces a…
Can GenepoweRx and MGI Tech’s AI-Driven Genomic Partnership…
Key Highlights: Strategic Alliance to Revolutionize Genomic MedicineIndian AI-driven startup GenepoweRx and China’s MGI Tech have joined forces…
Bexorg and Biohaven: Can Their AI-Driven Whole-Brain Discovery…
Key Highlights: Strategic Collaboration to Transform CNS TherapeuticsBexorg, a techbio innovator focused on decoding the human brain, has…
Tevogen AI & Microsoft: Will Their AI &…
Key Highlights HQ Expansion to Power AI, Generics & Biosimilar VisionTevogen Bio Holdings Inc. (Nasdaq: TVGN) has more…
AlphaMeld AI and VedTechBio: Can Their AI Alliance…
Key Highlights Strategic Alliance to Bridge AI Discovery and Translational ExecutionAlphaMeld Corporation, a global leader in AI-native drug…
Can This AI-Driven Biotech Duo Cut Biologic Development…
Key Highlights • AI-driven protein production from Axio BioPharma integrates with Likarda’s Core-Shell Spherification® (CSS®) delivery platform to…
95 Pathologists, 11 Hospitals, 1 AI Platform: Can…
Key Takeaways• 95 pathologists across 11 hospitals to adopt PathAI’s AISight® digital pathology platform, enabling real-time, AI-enhanced diagnostics•…
How Are the 2025 MedTech Breakthrough Awards Shaping…
Key Highlights: 1. TrustCommerce and Waystar: Leaders in Healthcare Payments InnovationTrustCommerce, a Sphere Company, has been honored with…
Trending Posts
Latest Stories
Is Theremia Using AI to Unlock Next-Generation Immuno-Oncology Therapies and Advance Pharma Partnerships?
Strategic Overview Theremia is emerging as a pioneering AI-driven biotech focused on immune system modulation…
Is Karyon Bio Using AI to Decode Disease Networks as Biopharma Moves Beyond Single-Target Drug Discovery?
Strategic Overview Karyon Bio is emerging as a next-generation AI-driven biotech focused on one of…
Is AION Labs Redefining AI Drug Discovery by Incubating Pharma-Native Startups from the Inside Out?
Strategic Overview AION Labs represents a structurally different model in the AI–biopharma landscape: a venture…
Is Ignota Labs Turning Pharma’s Failed Assets into a New AI-Driven Value Class?
Strategic Overview Ignota Labs is taking a fundamentally different approach to AI in biopharma—one that…
Gallery
